BEGIN:VCALENDAR METHOD:PUBLISH VERSION:2.0 CALSCALE:GREGORIAN PRODID:-//NONSGML WPForms//NONSGML Sugar Calendar Feeds v3.9.0//EN X-WR-CALNAME:RSV Expert Meeting 2026 X-WR-CALDESC:Immunisation Coalition X-WR-TIMEZONE:Australia/Melbourne BEGIN:VTIMEZONE TZID:Australia/Melbourne BEGIN:STANDARD TZOFFSETFROM:+1100 TZOFFSETTO:+1000 DTSTART:20260404T160000 TZNAME:AEST END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Australia/Melbourne BEGIN:STANDARD TZOFFSETFROM:+1100 TZOFFSETTO:+1000 DTSTART:20260404T160000 TZNAME:AEST END:STANDARD END:VTIMEZONE BEGIN:VEVENT SUMMARY:RSV Expert Meeting 2026 DESCRIPTION:Register for ONLINE\n\n\n\nIC Events\n\n\n\n\n\n\n\n\n\n\n\n \nDate: \;June 15\, 2026\, \;Time: \;7:00 pm to 9:00 pm (AES T)\n\n\n\nAbout\n\n\n\nThis meeting brings together healthcare professio nals\, policymakers\, and researchers to strengthen RSV vaccination effo rts. Insights and recommendations from the discussion will be documented and presented to the Government to help shape future immunisation progr ams and policies.\n\n\n\nDetails\n\n\n\nMarvel Stadium740 Bourke St\, Do cklands VIC 3008\n\n\n\n\nRegister for ONSITE\n\n\n\nRegister for ONLINE \n\n\n\n\n\n\n\n\n\n\n\n\nID: TBCThe RSV Expert Meeting 2026 will be RAC GP accredited for 2 CPD hours for online attendees.\n\n\n\nPresentations \n\n\n\n\n7:00 PMWelcome and opening commentsProf Hannah Moore▼\n\nA/P rof Hannah Moore OAM is an infectious disease epidemiologist\; Theme Hea d\, Infectious Diseases and Co-Head of the Infectious Disease Epidemiolo gy team at The Kids Research Institute Australia. She is also an Associa te Professor within the School of Population Health\, Curtin University and an Adjunct Associate Professor at University of Western Australia. S he is currently a Stan Perron Charitable Foundation Fellow and has recei ved further funding from the Future Health Research and Innovation Fund through the WA Near-miss Awards program.\n\n\n\nHer passion for research involves using population-based data to investigate how to recognise\, prevent and reduce serious respiratory and other infectious diseases in children through estimating burden of disease and evaluating the effecti veness of vaccination programs. She has developed expertise in the epide miology of Respiratory Syncytial Virus (RSV) in young children\, where h er research was pivotal in WA Governments’ decision to establish the f irst and most comprehensive RSV infant immunisation program in the natio n.\n\n\n\nRaising awareness of RSV\, understanding community burden and evaluating the impact of prevention measures is now a major focus of her research program\, partly funded by a $2.5M Perron Program Grant. She h as previously contributed to state and national influenza vaccination po licy.\n\n\n\nIn 2020 A/Prof Moore joined the Strep A Vaccine Global Cons ortium (SAVAC) to increase knowledge and awareness of the global burden of Group A Streptococcal diseases. She now holds an activity lead positi on in the US$11M-funded SAVAC 2.0.\n\n\n\nA/Prof Moore has been awarded >\;$19M in competitive research grants\, co-authored 150 papers\, was TEDxPerth 2018 speaker\, recipient of a WA Young Tall Poppy Award (2013) and the WA Premiers Science Early Career Scientist Award (2015). In 202 4\, she was honoured with a Medal of the Order of Australia for her serv ice to epidemiology as a researcher.\n\n\n\n\n\n7:10 PMMaternal RSV immu nisation program: learnings from 2025/6 and focuses for 2027 onwardsDr U shma Wadia▼\n\nDr Ushma Wadia is a consultant paediatrician with speci alisation in immunisation and infectious diseases at Perth Children’s Hospital and Fiona Stanley Hospital\, and medical lead at the Vaccine Tr ials Group within the Wesfarmers Centre of Vaccines and Infectious Disea ses\, The Kids Research Institute Australia. Dr Wadia has extensive expe rience in clinical and research vaccinology which allows patient\, famil y and community engagement to enhance vaccine confidence\, vaccine optim isation and uptake.\n\n\n\nShe is undertaking a PhD “Effectiveness of Respiratory Syncytial Virus (RSV) Prevention Strategies in Australian Ch ildren.” \;\n\n\n\nDr Wadia’s published results for the 2024 RSV program in WA provides the first real world effectiveness evidence demo nstrating nirsevimab effectiveness against RSV hospitalisation in Austra lia.\n\n\n\n\n\n07:30 PMState funded nirsevimab programs: learnings from 2025/6 and focuses for 2027 onwardsA/Prof Stephen Lambert▼\n\nStephen Lambert is a public health physician and medical epidemiologist who wor ks part time for both Queensland Health and the National Centre for Immu nisation Research and Surveillance. Stephen has worked in public health and been involved in vaccine preventable diseases research for over 25 y ears. Stephen enjoys gardening\, particularly failing to grow exotic Wes tern Australian banksias in Queensland\, walking his dog\, and listening to Sufjan Stevens music.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\ n\n\n\n\n\n\n7:50 PMRSV vaccines for older Australians: current options and where to now?Prof Charles Feldman▼\n\nProfessor Charles Feldman is currently Emeritus Professor\, Department of Internal Medicine\, Facult y of Health Sciences\, University of Witwatersrand\, Johannesburg\, Sout h Africa\, and Honorary Consultant (non-clinical) Monash Health\, Melbou rne\, Australia. He was previously Professor of Pulmonology and Chief Ph ysician at the Charlotte Maxeke Johannesburg Academic Hospital and the U niversity of the Witwatersrand\, between 1995 and 2017. Professor Feldma n’s research interest is in the field of community-acquired pneumonia\ , particularly pneumococcal pneumonia\, as well as in the role of vaccin es in the prevention of vaccine-preventable respiratory tract infections in adults. Professor Feldman has been active on several national and in ternational scientific committees. He was on two separate occasions the President of the South African Thoracic Society. He was elected as a Fel low of the European Respiratory Society in 2014 and the American Thoraci c Society in 2017 in recognition of his contributions to the field of re spiratory medicine. In 2018 he received the Platinum Gold Medal from the South African Medical Research Council for a lifetime of research in hu man health. In 2021\, the University of Pretoria (UP) bestowed an honora ry Doctor of Medicine degree (honoris causa) on Professor Feldman for hi s significant contribution to the field of pneumococcal respiratory infe ctions. Professor Feldman has presented at numerous international meetin gs and congresses\, has more than 400 publications in international lite rature and more than 16000 citations\, and is a National Research Founda tion (SA) rated Scientist.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPanel Di scussion\n\n\n\nA. Delivering on strategies to vaccinate against RSV dur ing pregnancy and in children up to 2 years oldB. Older adults: vaccinat ion strategies for current RSV funded programs\n\n\n\n\n8:30 PMPanel Dis cussion▼\n\nModerator: Dr Sarah Chu \;\n\n\n\nDr Sarah Chu graduat ed from the University of Queensland in 2004 with a Bachelor of Medicine and Bachelor of Surgery. She is a member of the International Society o f Travel Medicine and has a Certificate in Travel Health\; she enjoyed p roviding travel medicine services at The Travel Doctor TMVC Brisbane bef ore COVID-19 and is an accredited Yellow Fever doctor. In addition to be ing awarded a Fellowship from the Royal Australian College of General Pr actitioners\, she is a Fellow of The Australasian College of Tropical Me dicine\, Fellow of The Australasian College of Tropical Medicine (Facult y of Travel Medicine)\, Associate Member of the Faculty of Travel Medici ne Royal College of Physicians and Surgeons of Glasgow\; Dr Chu also hol ds a Diploma in Dermatology from the Australian Institute of Dermatology \, and a Diploma in Child Health from Westmead Children’s Hospital and the University of Sydney. She enjoys practising yoga and is a registere d level 1 yoga teacher with Yoga Australia. Dr Chu recently completed Ph ysician Board Certification in Lifestyle Medicine with the International Board of Lifestyle Medicine. She is a Senior Lecturer for the Universit y of Queensland and enjoys teaching the next generation of doctors-in-tr aining.\n\n\n\n\n\nProfessor Charles Feldman\n\n\n\nProfessor Charles Fe ldman is currently Emeritus Professor\, Department of Internal Medicine\ , Faculty of Health Sciences\, University of Witwatersrand\, Johannesbur g\, South Africa\, and Honorary Consultant (non-clinical) Monash Health\ , Melbourne\, Australia. He was previously Professor of Pulmonology and Chief Physician at the Charlotte Maxeke Johannesburg Academic Hospital a nd the University of the Witwatersrand\, between 1995 and 2017. Professo r Feldman’s research interest is in the field of community-acquired pn eumonia\, particularly pneumococcal pneumonia\, as well as in the role o f vaccines in the prevention of vaccine-preventable respiratory tract in fections in adults. Professor Feldman has been active on several nationa l and international scientific committees. He was on two separate occasi ons the President of the South African Thoracic Society. He was elected as a Fellow of the European Respiratory Society in 2014 and the American Thoracic Society in 2017 in recognition of his contributions to the fie ld of respiratory medicine. In 2018 he received the Platinum Gold Medal from the South African Medical Research Council for a lifetime of resear ch in human health. In 2021\, the University of Pretoria (UP) bestowed a n honorary Doctor of Medicine degree (honoris causa) on Professor Feldma n for his significant contribution to the field of pneumococcal respirat ory infections. Professor Feldman has presented at numerous internationa l meetings and congresses\, has more than 400 publications in internatio nal literature and more than 16000 citations\, and is a National Researc h Foundation (SA) rated Scientist.\n\n\n\n\n\n\n\n\n\nMBBS (Hons)\, FRAC GP\, Grad Cert Clin Teach\, MPH\, GAICD\n\n\n\nDr Anita Muñoz worked as a Clinical Editor and Clinical Advisor for 6 years with North Western M elbourne PHN through which a passion for health system improvement\, inn ovation\, sustainability\, and equity emerged. She sees general practice as the key to a rational health system that produces better outcomes fo r patients and practitioners alike. Anita Muñoz is a GP in private prac tice in Melbourne's CBD and has a dedication to evidence-based medicine\ , lifelong learning\, and promoting the role of general practice in the health of patients\, communities and in public health more broadly.\n\n\ n\nAnita has held advisory positions with Better Care Victoria and Safer Care Victoria and has been a medical educator for over 9 years. She is particularly preoccupied with the wellbeing and experience of general pr actice registrars\, and of securing a high-quality general practice work force for the future.\n\n\n\n\n\n\n\n\n\nKaz Bellamay\n\n\n\nKaz Bellamy is an Infectious Diseases and Immunisation Nurse Practitioner with spec ialist expertisein highrisk\, antenatal\, and travel immunisation. Kaz h as played a key role in developing adult andpaediatric immunisation seda tion pathways at Monash Health. With extensive experience in vaccinesafe ty and vaccinepreventable disease research across both adult and paediat ric populations\, Kazbrings strong clinical and research leadership to i mmunisation practice. Kaz is a current member ofthe Australian Technical Advisory Group on Immunisation (ATAGI).\n\n\n\n\n\n\n\n\n\n\n\n\n\nHave n Moushi\n\n\n\nHaven is a community pharmacist and proprietor of two ph armacies in Victoria\, with over 10 years of experience as an accredited pharmacist immuniser. She is actively involved in the Monash University Intern Training Program (ITP) vaccination program\, supporting the deve lopment of future pharmacists through practical immunisation training an d mentorship\, ensuring they are confident and well-prepared to deliver vaccination services.\n\n\n\nHaven also has extensive experience deliver ing off-site vaccination clinics\, including within aged care facilities \, helping improve access to essential vaccines for vulnerable populatio ns and supporting broader public health initiatives.\n\n\n\nAs a pharmac y owner\, she integrates immunisation services into everyday practice\, fostering a culture of prevention and proactive healthcare within her te am. She is committed to expanding the role of pharmacists in primary car e and advocating for increased accessibility to vaccinations across dive rse communities.\n\n\n\nHaven continues to contribute to the profession through leadership\, practical experience\, and a strong dedication to a dvancing pharmacist-led immunisation services.\n\n\n\n\n\n\nSummary and Closing\n\n\n\n\n9:00 PMClosing commentsProf Hannah Moore▼\n\n\n\n\n\n A/Prof Hannah Moore OAM is an infectious disease epidemiologist\; Theme Head\, Infectious Diseases and Co-Head of the Infectious Disease Epidemi ology team at The Kids Research Institute Australia. She is also an Asso ciate Professor within the School of Population Health\, Curtin Universi ty and an Adjunct Associate Professor at University of Western Australia . She is currently a Stan Perron Charitable Foundation Fellow and has re ceived further funding from the Future Health Research and Innovation Fu nd through the WA Near-miss Awards program.\n\n\n\nHer passion for resea rch involves using population-based data to investigate how to recognise \, prevent and reduce serious respiratory and other infectious diseases in children through estimating burden of disease and evaluating the effe ctiveness of vaccination programs. She has developed expertise in the ep idemiology of Respiratory Syncytial Virus (RSV) in young children\, wher e her research was pivotal in WA Governments’ decision to establish th e first and most comprehensive RSV infant immunisation program in the na tion.\n\n\n\nRaising awareness of RSV\, understanding community burden a nd evaluating the impact of prevention measures is now a major focus of her research program\, partly funded by a $2.5M Perron Program Grant. Sh e has previously contributed to state and national influenza vaccination policy.\n\n\n\nIn 2020 A/Prof Moore joined the Strep A Vaccine Global C onsortium (SAVAC) to increase knowledge and awareness of the global burd en of Group A Streptococcal diseases. She now holds an activity lead pos ition in the US$11M-funded SAVAC 2.0.\n\n\n\nA/Prof Moore has been award ed >\;$19M in competitive research grants\, co-authored 150 papers\, w as TEDxPerth 2018 speaker\, recipient of a WA Young Tall Poppy Award (20 13) and the WA Premiers Science Early Career Scientist Award (2015). In 2024\, she was honoured with a Medal of the Order of Australia for her s ervice to epidemiology as a researcher.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSpo nsors\n\n\n\nWe would like to thank the following companies for supporti ng this event: URL;VALUE=URI:https://immunisationcoalition.org.au/events/rsv-expert-mee ting/ UID:urn:uuid:861c547d-6466-4fc4-83dd-76af05c929c7 STATUS:CONFIRMED ORGANIZER: DTSTAMP:20260519T032130Z DTSTART;TZID=Australia/Melbourne:20260615T190000 DTEND;TZID=Australia/Melbourne:20260615T211000 END:VEVENT END:VCALENDAR